Predict your next investment

HEALTHCARE | Drug Development
pcovery.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$5.72M

Last Raised

$5.72M | 8 yrs ago

About Pcovery

Pcovery is a provider in structure based drug development against membrane protein drug targets with a broad portfolio of innovative technologies, drug targets and chemical products.

Pcovery Headquarter Location

Thorvaldsensvej 57

Frederiksberg, 1871,

Denmark

+45 5159 4560

Latest Pcovery News

Pcovery ApS Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250

Mar 18, 2017

Pcovery ApS Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 21022017] Prices from USD $250 11:04 EDT 18 Mar 2017 | BioPortfolio Reports Home » Topics » Healthcare » Latest News » Pcovery ApS Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 21022017] Prices from USD $250 Summary Pcovery ApS Pcovery is a healthcare company that offers drug discovery services. The company develops a novel class of anti fungal drugs for the treatments of invasive fungal infections. It screens for a drug that can selectively shut down an essential plasma membrane transport system in the fungi, and thereby killing them. Pcovery's development project provides a membrane protein found in the fungal cell membrane. The company operates in antifungal drug development, chemistry, biochemistry, structural biology and membrane transport. Its research platform utilizes a number of technologies to identify, evaluate and optimize novel antifungal compounds. The company operates through companies and research centers to develop its products. Pcovery is headquartered in Kobenhavn, Denmark. Pcovery ApS Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pcovery

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pcovery is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.